Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Woodward–Hoffmann Selection Rules and Microscopic Reversibility01:34

Woodward–Hoffmann Selection Rules and Microscopic Reversibility

Electrocyclic reactions, cycloadditions, and sigmatropic rearrangements are concerted pericyclic reactions that proceed via a cyclic transition state. These reactions are stereospecific and regioselective. The stereochemistry of the products depends on the symmetry characteristics of the interacting orbitals and the reaction conditions. Accordingly, pericyclic reactions are classified as either symmetry-allowed or symmetry-forbidden. Woodward and Hoffmann presented the selection criteria for...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

The ITCC-P4 PDX Platform Enables Preclinical Testing of Pediatric Cancers.

Cancer research·2026
Same author

Frequency and Prognostic Significance of Genetic Abnormalities in a Subgroup of Patients With Intermediate-Risk Neuroblastoma: A SIOPEN Study.

JCO precision oncology·2026
Same author

Proposal of a Risk Stratification Algorithm for Extracranial Malignant Rhabdoid Tumors.

Cancer medicine·2026
Same author

circVDJ-seq for T cell clonotype detection in single-cell and spatial multi-omics.

Genome medicine·2026
Same author

A pilot study combining primary busulfan-based haploidentical stem cell transplantation with GD2 antibody to treat high-risk neuroblastoma.

Bone marrow transplantation·2026
Same author

Comprehensive molecular analyses for diagnosis and treatment guidance in an adult neuroblastoma patient.

The oncologist·2026

Related Experiment Video

Updated: May 10, 2026

Laser Capture Microdissection of Glioma Subregions for Spatial and Molecular Characterization of Intratumoral Heterogeneity, Oncostreams, and Invasion
09:09

Laser Capture Microdissection of Glioma Subregions for Spatial and Molecular Characterization of Intratumoral Heterogeneity, Oncostreams, and Invasion

Published on: April 12, 2020

Logic Learning Machine creates explicit and stable rules stratifying neuroblastoma patients.

Davide Cangelosi1, Fabiola Blengio, Rogier Versteeg

  • 1Laboratory of Molecular Biology, Gaslini Institute, Largo Gaslini 5, 16147 Genoa, Italy.

BMC Bioinformatics
|July 3, 2013
PubMed
Summary

A new classification model accurately predicts neuroblastoma patient outcomes by integrating clinical data with a hypoxia gene signature (NB-hypo). This approach identifies high-risk patients for targeted therapies, improving survival rates for this common pediatric cancer.

More Related Videos

Machine Learning Algorithms for Early Detection of Bone Metastases in an Experimental Rat Model
07:15

Machine Learning Algorithms for Early Detection of Bone Metastases in an Experimental Rat Model

Published on: August 16, 2020

Related Experiment Videos

Last Updated: May 10, 2026

Laser Capture Microdissection of Glioma Subregions for Spatial and Molecular Characterization of Intratumoral Heterogeneity, Oncostreams, and Invasion
09:09

Laser Capture Microdissection of Glioma Subregions for Spatial and Molecular Characterization of Intratumoral Heterogeneity, Oncostreams, and Invasion

Published on: April 12, 2020

Machine Learning Algorithms for Early Detection of Bone Metastases in an Experimental Rat Model
07:15

Machine Learning Algorithms for Early Detection of Bone Metastases in an Experimental Rat Model

Published on: August 16, 2020

Area of Science:

  • Pediatric Oncology
  • Molecular Diagnostics
  • Computational Biology

Background:

  • Neuroblastoma, a common pediatric solid tumor, has a high mortality rate in high-risk patients, necessitating improved prognostic strategies.
  • Tumor hypoxia, a marker of poor prognosis, is quantified by the NB-hypo gene expression signature, a previously established molecular risk factor.
  • Current risk stratification methods require enhancement by integrating clinical and molecular factors for better patient outcome prediction.

Purpose of the Study:

  • To develop a prognostic classifier for neuroblastoma patients by combining clinical risk factors with the NB-hypo signature.
  • To create a classifier that generates explicit, clinically translatable rules for risk stratification.
  • To identify a new class of high-risk neuroblastoma patients who may benefit from novel therapeutic interventions.

Main Methods:

  • Utilized the Shadow Clustering (SC) technique, resulting in Logic Learning Machine (LLM) models for classification.
  • Classified neuroblastoma patients based on age at diagnosis, INSS stage, MYCN amplification, and the NB-hypo signature.
  • Employed an iterative procedure to refine the classifier by removing unstable data points, ensuring rule stability and accuracy.

Main Results:

  • The LLM classifier generated explicit rules consistent with existing clinical knowledge.
  • A stable and highly accurate classifier was developed, effectively predicting both good and poor patient outcomes.
  • The NB-hypo signature proved to be a significant factor in the classification rules, comparable in importance to tumor staging.
  • Classifier performance was validated on an independent patient dataset.

Conclusions:

  • The study highlights the importance of classifier stability, explicit rules, and the integration of molecular and clinical data for neuroblastoma patient stratification.
  • A novel set of four stable rules was derived, identifying a distinct group of poor-outcome patients.
  • These findings suggest potential new therapeutic strategies targeting tumor hypoxia or its downstream effects for improved patient management.